Publications by authors named "Lothar Seefried"

Claim this Profile
A
A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis.
Lothar Seefried, Serge Ferrari, Dénes Páll, Ombretta Viapiana, Jan Rosa

Osteoporos Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diagnosis of osteoporosis-importance of dual-energy X-ray absorptiometry].
Franca Genest, Lothar Seefried

Z Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized Phase 1b trial evaluating the pharmacodynamics of ilofotase alfa in adults with hypophosphatasia.
Lothar Seefried, Juliane Bernholz, Maarten Kraan, Yvonne Nitschke, Frank Rutsch

J Bone Miner Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Global Hypophosphatasia Registry: lessons learned from a decade of real-world data.
Priya S Kishnani, Lothar Seefried, Keiichi Ozono, Gabriel Ángel Martos-Moreno, Cheryl Rockman-Greenberg

Orphanet J Rare Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XLH Matters 2024: expert insights and practical tools for enhancing care of people living with X-linked hypophosphataemia.
Lothar Seefried, Ali S Alzahrani, Carsten A Wagner, Damian Eade, Danilo Fintini

Orphanet J Rare Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical phenotype of hypophosphatasia in asymptomatic individuals carrying ALPL variants.
Rodrigo Montero-Lopez, Mariam R Farman, Florian Högler, Catherine Rehder, Theodora Malli, Lothar Seefried

J Bone Miner Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ALPL gene variant project: results of the first 100 reclassified variants.
Mariam R Farman, Theodora Malli, Catherine Rehder, Gerald Webersinke, Cheryl Rockman-Greenberg, Lothar Seefried

JBMR Plus· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlations between 6-minute walk test, chair-rise test, and lower extremity functional scale among patients with hypophosphatasia.
Lothar Seefried, Franca Genest

Bone Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.
Dieter Haffner, Francesco Emma, Lothar Seefried, Wolfgang Högler, Kassim M Javaid

Nat Rev Nephrol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.
Dieter Haffner, Francesco Emma, Lothar Seefried, Wolfgang Högler, Kassim M Javaid

Nat Rev Nephrol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a Standardised Dataset for Natural History Studies in Fibrous Dysplasia/McCune-Albright Syndrome.
Ana Luisa Priego Zurita, Oana O Bulaicon, Jillian Bryce, Nerea Arrieta, Magdalena Caballero Campos, Lothar Seefried

Calcif Tissue Int· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel therapeutic options for hypophosphatasia.
Wolfgang Högler, Lothar Seefried

J Bone Miner Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Grading Pseudofractures-The "Breach-Beak-Bump-Bridge" Approach.
Lothar Seefried, Dominik Rak, Franca Genest

Calcif Tissue Int· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease burden by variant number in patients with non-life-threatening hypophosphatasia in the Global HPP Registry.
Priya S Kishnani, Lothar Seefried, Kathryn M Dahir, Gabriel Á Martos-Moreno, Wolfgang Högler

J Med Genet· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XLH Matters: an evolving programme to discuss new advances and share clinical experiences to improve patient outcomes.
Lothar Seefried, Ferdinando Aliberti, Cathrine Alsaker Heier, Pedro Arango-Sancho, Martin Biosse Duplan

Orphanet J Rare Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and safety of impact-loading exercise in patients with multiple myeloma-a pilot study.
Anne Kollikowski, Marei Schallock, Ruben Ringeisen, Dirk Hasenclever, Lothar Seefried

Support Care Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New insights into the landscape of ALPL gene variants in patients with hypophosphatasia from the Global HPP Registry.
Priya S Kishnani, Lothar Seefried, Kathryn M Dahir, Gabriel Ángel Martos-Moreno, Agnès Linglart

Am J Med Genet A· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole genome sequencing in adults with clinical hallmarks of hypophosphatasia negative for ALPL variants.
Lothar Seefried, Anna Petryk, Guillermo Del Angel, Felix Reder, Peter Bauer

Mol Biol Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical presentation and burden of ENPP1 deficiency in adults.
Lothar Seefried

Arch Pediatr· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults.
Aliya A Khan, Maria Luisa Brandi, Eric T Rush, Dalal S Ali, Hatim Al-Alwani, Lothar Seefried

Osteoporos Int· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance.
Maria Luisa Brandi, Aliya A Khan, Eric T Rush, Dalal S Ali, Hatim Al-Alwani, Lothar Seefried

Osteoporos Int· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults.
Aliya A Khan, Maria Luisa Brandi, Eric T Rush, Dalal S Ali, Hatim Al-Alwani, Lothar Seefried

Osteoporos Int· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global registry.
Priya S Kishnani, Gabriel Ángel Martos-Moreno, Agnès Linglart, Anna Petryk, Andrew Messali, Lothar Seefried

Orphanet J Rare Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group.
Eric Rush, Maria Luisa Brandi, Aliya Khan, Dalal S Ali, Hatim Al-Alwani, Lothar Seefried

Osteoporos Int· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Restricted Phosphorus, Calcium-adjusted Diet on Musculoskeletal and Mental Health in Hypophosphatasia.
Katinka Kuehn, Andreas Hahn, Lothar Seefried

J Endocr Soc· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis